Arena Pharma (ARNA) – Momentum Movers
-
Arena Pharma (ARNA) Gains 20% Pre-Market Following Strong Q4 Results
-
Arena Pharma (ARNA) Unit, Roivant Sciences Enter Nelotanserin Development, Supply Agreement
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Back to ARNA Stock Lookup